See the link below with more information. However, the article notes:

“Conclusions: The current study provides long-term outcome data on JAK2 exon 12 mutated PV, which appear to be similar to those of JAK2 V617F mutated disease”

https://ashpublications.org/blood/article/130/S...

I did not know there was another besides jak2v617f. I would also like to know which is more aggressive.

WR, thank U.

Thank you!